Yaz, Yasmin makers get approval for new birth control pill
As Bayer HealthCare begins defending itself against a flurry of lawsuits citing health problems over its blockbuster birth control pills Yaz and Yasmin, the drug company announced it has received approval from the Food and Drug Administration (FDA) on a new oral contraceptive. Bayer’s Natazia combines the hormones estrogen and progestin in doses that adjust four times throughout a women’s menstruation cycle. Natazia is the first birth control pill to use the four-phase dosing protocol with the added benefit of controlling irregular bleeding better than other pills.